Role of sonomammography in monitoring the response of neoadjuvant chemotherapy in malignant breast masses
ConclusionThe ability of mammography and breast ultrasound to accurately measure residual tumor size following neoadjuvant chemotherapy compared to Breast MRI measurement of the residual tumor demonstrated sensitivity of 94.12 % and specificity of 83.33% with high accuracy value reaching to 91.30 %. Even that the MRI is proved to be of high accuracy in detecting residual tumor, sonomammographic imaging isa cost-effective imaging modality than the MRI with sensitivity and specificity near to that of MRI.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Disability | Ductal Carcinoma | Internal Medicine | Lobular Carcinoma | Mammography | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology | Study | Ultrasound | Women